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Abstract	Incentives	have	been	proposed	to	NHS	hospitals	to	encourage	the	collection	of	‘quality’	umbilical	UCB	(UCB)	to	treat	people	with	blood	disorders.	As	UCB	is	collected	immediately	after	a	woman	has	given	birth,	maternity	practices	have	come	under	scrutiny.	Sixty-two	interviews	were	conducted	between	2009	and	2010	with	those	working	on	maternity	wards,	and	in	UCB	collection	and	banking.	Ethical	approval	was	granted	by	the	university	institution	and	the	NHS	Research	Ethics	Committee.	Participants	perceived	a	conflict	between	acquiring	a	‘quality’	UCB	sample	for	blood	disease	sufferers	and	concerns	for	maternal	and	neonatal	health.	Options	to	overcome	the	conflict	were	compromises	that	demonstrated	that	those	most	powerful	in	the	debates	are	those	conducting	maternity	practices,	whilst	those	involved	in	the	banking	of	UCB	have	less	influence	perhaps	as	a	consequence	of	the	lower	priority	of	‘quality’	UCB	collection	in	relation	to	maternal	and	neonatal	health.			Key	words:	clinical	pragmatism,	maternity	practices,	umbilical	cord	blood			
Introduction	Midwives	and	obstetricians	have	longed	raised	concerns	over	the	implications	of	umbilical	cord	blood	(UCB)	collection	on	maternal	and	neonatal	health.	Their	anxieties	have	predominately	focused	upon	the	timing	of	when	the	UCB	was	collected.	Maternity	staff	were	fearful	that	if	they	were	expected	to	collect	UCB	they	would	be	distracted	from	caring	for	the	new	mother	and	baby	“at	a	time	of	significantly	increased	clinical	risk	immediately	post-delivery.”	(Edozien	2006;	Regan,	Bewley,	and	Warwick	2008)	These	fears	have	been	allayed	to	some	extent	since	the	Human	Tissue	Authority’s	decision	to	introduce	dedicated	personnel	to	collect	UCB	(Human	Tissue	Authority	2008;	Machin,	Brown,	and	McLeod	2012)	and	promotion	
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by	the	Royal	Colleges	for	collection	to	take	place	following	the	delivery	of	the	placenta	so	that	collection	takes	place	ex-utero	(Royal	College	of	Obstetricians	and	Gynaecologists	2006).		However,	midwives’	and	obstetricians’	long-standing	debate	surrounding	the	timing	of	when	the	umbilical	cord	is	clamped,	and	the	potential	health	implications	for	babies	and	children	as	a	result,	such	as	neurodevelopment	delays	and	iron	deficiencies	identified	in	children	up	to	the	age	of	four	years	old	if	clamped	‘immediately,’	(Mercer	and	Erickson-Owens	2006;	Eichenbaum-Pikser	and	Zasloff	2009;	Andersson	et	al.	2011;	Andersson	et	al.	2015)	or	preventing	jaundice	(Mercer	2001),	and	lowering	cases	of	anaemia	(Andersson	et	al.	2011)	if	clamping	is	‘deferred,’	is	still	on-going	(Royal	College	of	Obstetricians	and	Gynaecologists	2015).	The	collection	of	UCB	has	contributed	another	layer	to	the	arguments	over	the	timing	of	when	the	umbilical	cord	is	clamped,	with	‘immediate’	clamping	perceived	as	facilitating	collection	(Diaz-Rossello	2006;	Brown	2013)	and	‘deferred’	clamping	as	hindering	collection	(Andersson	et	al.	2011;	Burgess	and	Hilton	2012).		Despite	their	concerns,	not	only	has	UCB	collection	continued,	with	approximately	20	thousand	samples	stored	in	the	public	bank	in	England	(Pawson	2014),	but	United	Kingdom	(UK)	Government	has	recently	invested	an	additional	£4	million	in	order	to	increase	the	amount	of	UCB	samples	collected	and	stored	in	the	bank	up	to	50,000	(Burgess	and	Hilton	2012).	The	public	bank	has	recently	formed	in	2011,	after	a	collaboration	between	two	previously	separate	banks	run	by	the	charity,	The	Anthony	Nolan	Trust,	and	the	other	by	the	NHS	Blood	and	Transplant	(Williams	2015).	Publicly	banked	units	are	made	available	globally	through	international	registries,	although	the	collection	of	UCB	falls	within	the	responsibility	of	the	Human	Tissue	Authority	and	is	regulated	by	the	Human	Tissue	Act	(2004).	Numerous	international	organisations	have	been	established	in	an	attempt	to	ensure	“high	and	uniform	quality	of	all	UCB	units”	(Petrini	2012).	The	accreditation	systems	available	through	these	organisations,	such	as	FACT	and	JACIE,	are	thought	to	provide	reassurance	through	setting	
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uniform	standards	for	the	collection,	processing,	banking	and	transplant	elements	relating	to	UCB	(Pamphilon	2009).			Umbilical	cord	blood	is	used	to	treat	people	with	blood	disorders,	such	as	leukaemia,	sickle	cell	anaemia,	and	thalassemia,	although	this	is	dependent	upon	a	UCB	sample	with	an	appropriate	immunological	type	being	available	from	UK	public	bank	(Samuel	and	Kerridge	2007).	Many	factors	can	influence	whether	‘appropriate’	UCB	samples	are	available,	including	the	number	of	UCB	samples	collected	and	stored	in	banks.	So,	whilst	112	UCB	units	were	used	to	treat	NHS	patients	in	2010,	proponents	of	UCB	collection	argue	that	approximately	four	hundred	and	forty	additional	patients	each	year	could	benefit	from	treatments	using	UCB	if	UK	bank	of	50	thousand	samples	were	available	(UK	Stem	Cell	Strategic	Forum	2010).			However,	even	if	an	immunological	matched	UCB	sample	is	available	in	the	bank,	this	does	not	guarantee	it	is	deemed	‘appropriate’	for	transplantation.		Those	using	UCB	samples	to	treat	patients	have	questioned	the	‘quality’	of	some	of	the	samples	collected	(McCullough	et	al.	2005;	Picardi	and	Arcese	2010;	Querol	et	al.	2010).	In	particular,	the	volume	of	UCB	collected	in	each	sample	can	influence	whether	it	is	useful	for	treatment	or	not	(Ballen	et	al.	2001;	Jones	et	al.	2003;	Bart	et	al.	2013).	A	stored	unit	typically	contains	a	sufficient	volume	of	blood	to	treat	a	small	child,	therefore	multiple	units	are	needed	to	treat	an	adult.	In	order	to	drive	‘quality’,	some	public	banks	are	setting	a	minimum	volume	–	ranging	from	70ml	to	100ml	-	of	UCB	to	be	within	each	sample	stored,	although	no	universal	standard	currently	exists	across	all	banks	(Diaz-Rossello	2006).	As	a	result,	transplant	teams	may	choose	to	import	a	UCB	sample	from	an	overseas	bank,	which	can	prove	costly	(approximately	£16,000	-	£30,000)	(Brown,	Machin,	and	McLeod	2011;	Williams	2015).		Reports	in	2010	from	the	World	Marrow	Donor	Association,	which	track	the	activities	of	UCB	banks	globally,	stated	that	the	percentage	of	UCB	units	crossing	international	borders	was	increasing	(Foeken	et	al.	2010).	In	particular,	European	countries,	such	as	Hungary,	France,	
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and	Italy,	had	imported	more	UCB	units	to	meet	clinical	need	compared	to	using	UCB	units	collected	within	their	own	country	(Katz	and	Mills	2010).	Some	countries	have	attempted	to	overcome	this	economic	burden	by	introducing	policies	that	constrain	public	freedoms	in	UCB	banking	choices,	such	as	France	prohibiting	commercial	banking	(Katz	and	Mills	2010;	Dickenson	2011).	Between	2011	and	2012,	80	percent	of	all	UCB	samples	used	for	UK	patients	were	imported	(Burgess	and	Hilton	2012),	and	therefore	in	an	attempt	to	reduce	the	UK’s	reliance	on	imported	UCB	samples,	the	All	Party	Parliamentary	Group	(APPG)	on	Stem	Cell	Transplantation	at	Westminster	has	proposed	a	number	of	incentives	to	NHS	hospitals	in	order	to	encourage	the	collection	of	‘quality’	UCB	(Burgess	and	Hilton	2012).	As	UCB	is	collected	immediately	after	a	woman	has	given	birth,	maternity	practices,	such	as	cord	clamping	and	management	of	the	third	stage	of	labour,	have	come	under	scrutiny	from	those	keen	to	generate	‘quality’	UCB	samples	through	increasing	the	volume	of	UCB	collected	(Jones	et	al.	2003;	Brown	2013).	Consequently,	midwives,	obstetricians	and	neonatologists,	who	conduct	maternity	practices,	have	found	themselves	embroiled	in	the	debates	surrounding	‘quality’	UCB	samples	(Diaz-Rossello	2006).	It	is	of	interest	therefore	to	explore	how	these	emerging	and	existing	stakeholders	in	UCB	collection	and	banking	discuss	maternity	practices	in	light	of	the	recent	drive	for	the	collection	of	‘quality’	UCB	samples.	In	particular,	a	focus	upon	the	interplay	between	these	stakeholders	in	UCB	collection	and	banking	offers	insight	into	the	conflicts	and	compromises	that	are	shaping	the	debates	surrounding	the	collection	of	‘quality’	UCB.		
Conflicts	and	Compromises	within	Cord	Blood	Debates	The	field	of	cord	blood	collection	and	banking	is	rife	with	conflicts	and	compromises,	not	least	because	of	the	attempt	to	combine	commercial	activities	within	a	public	healthcare	system.	The	early	debates	surrounding	the	introduction	of	commercial	banks	dominate	past	
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research	(Querol	2007),	with	the	ethical	and	legal	considerations,	such	as	rationing	of	resources,	staffing	shortages,	and	fear	of	litigation,	raised	by	those	involved	in	UCB	banking	and	maternity	practices	(Edozien	2006;	Hollands	2006).	More	recently,	academic	researchers	have	identified	aspects	of	the	UCB	collection	process	that	are	significant,	such	as	gathering	consent	from	the	pregnant	woman	(Busby	2010),	or	potentially	controversial,	such	as	ownership	of	the	UCB	(Kline	2001).	Reflexively,	researchers	have	explored	the	sources	of	conflicts	within	the	field	of	UCB	collection	and	banking,	but	few	have	done	so	explicitly	or	considered	how	the	application	of	compromise	literature	can	inform	our	understanding	of	the	debating	surrounding	UCB.	Specifically,	it	is	rare	for	the	relationships	between	those	involved	in	UCB	banking	and	maternity	practices	to	be	explored	by	researchers	(Fisk	and	Atun	2008;	Fox,	Chervenak	and	McCullough	2008).	Yet,	researchers	do	acknowledge	the	significance	of	the	relationships	when	contemplating	the	realities	of	introducing	commercial	UCB	banks	in	the	NHS,	in	particular,	the	power	that	midwives	and	obstetricians	have	to	“help	overturn	entrenched	professional	opposition	to	commercial	banking”	(Fisk	and	Atun	2008).	This	paper	will	attend	to	this	gap	by	applying	a	method	designed	to	explore	the	ethical	conflicts	within	clinical	practice	(discussed	below),	and	focusing	on	the	compromises	reached	between	those	involved	in	UCB	banking	and	maternity	practices,	and	interpreting	these	findings	within	the	compromise	literature	discussed	next.					
Some	Meanings	of	Conflicts	and	Compromises	The	proposition	of	a	compromise	suggests	that	a	conflict	is	possible	or	in	existence	(Golding	1979;	Nachi	2004)	and	that	it	stems	from	‘political’	problems	(Hallowell	1944).	So,	whilst	the	presence	of	a	compromise	acts	as	an	acknowledgement	of	the	other	stakeholder,	and	gives	‘significance’	to	their	place	in	the	debate	(Nachi	2004;	Menkel-Meadow	2006),	not	all	stakeholders	are	equal,	and	instead	the	balance	of	power	can	tip	in	the	favour	of	some	over	
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others	(Arnsperger	and	Picavet	2004;	Menkel-Meadow	2006).	Examining	the	negotiation	process	therefore	can	highlight	the	power	dynamics	at	play	(Nachi	2004)	and	provide	insight	into	whom	or	what	is	being	negotiated	for	or	over,	thereby	reflecting	the	needs	or	interests	of	specific	parties	(Menkel-Meadow	2006).	Consequently,	insight	into	the	roles	and	relationships	of	key	stakeholders	in	cord	blood	banking	and	maternity	practices	is	essential,	as	it	enable	us	to	learn	how	the	interactions	between	the	two	stakeholder	groups	are	reflected	in	policy	and	practice	today.		Compromises	are	unpredictable,	rarely	fixed	or	static,	particularly	if	new	evidence	emerges,	and	therefore	the	balance	of	power	can	shift	between	stakeholders	(Papilloud	and	Rol	2004;	Hussenot	2010).	This	is	significant	for	the	debates	surrounding	UCB	collection	and	maternity	practices	as	recent	clinical	trials	in	cord	blood	transplantation,	ongoing	scientific	research	to	develop	techniques	to	expand	small	volumes	of	UCB	collected,	and	current	large	scale	cohort	studies	into	the	consequences	of	cord	clamping	(Hollands	and	McCauley,	2009)	all	bring	the	potential	of	new	evidence,	and	in	turn,	the	shifting	of	power	between	stakeholders.	Therefore,	this	paper	will	explore	the	evolution	of	a	compromise	emerging	from	the	debates	surrounding	the	collection	of	‘quality’	UCB,	which	will	provide	an	explanation	for	the	production	and	reproduction	of	policies	and	practices	(Hussenot	2010)	in	UCB	collection	and	maternity	practices	in	England.			
A	Closer	Look	at	UCB	Collection	and	Maternity	Practices	in	England	Umbilical	cord	blood	can	be	collected	for	either	a	public	or	a	commercial	bank.	There	are	three	fundamental	differences	between	the	two	types	of	banks.	Firstly,	once	a	baby	is	born,	a	woman	can	donate	the	blood	from	the	umbilical	cord	to	UK	public	banks,	or	pay	to	store	the	blood	in	a	commercial	bank.	Secondly,	the	donated	UCB	in	the	public	banks	is	available	to	patients	worldwide,	whereas	the	UCB	in	commercial	banks	is	available	solely	to	the	family	that	paid	for	
	7		
the	storage.	Commercial	banks	can	store	units	with	a	lower	volume	of	UCB	than	the	standard	set	by	public	banks	if	families	agree.	Consequently,	commercially-collected	UCB	for	familial	use	has	generated	much	debate,	particularly	surrounding	the	viability	of	the	samples	for	transplantation	(Edozien	2006;	Mohr	et	al.	2012).	Finally,	UCB	can	be	collected	for	both	types	of	banks	within	specific	NHS	hospitals.	However,	donor	co-ordinators	are	employed	by	the	public	banks	to	carry	out	the	collections,	whereas	phlebotomists	are	contracted	by	pregnant	women	to	collect	the	UCB	to	be	stored	in	commercial	banks	(Edozien	2006;	Machin,	Brown,	and	McLeod	2012).		Despite	these	differences	between	the	types	of	banks,	the	process	of	collection	by	the	donor	co-ordinators	or	phlebotomists,	is	thought	to	be	similar.	The	midwife	or	obstetrician	places	the	umbilical	cord	in	a	dish,	which	is	handed	over	to	the	donor	co-ordinators	or	phlebotomists,	who	may	or	may	not	be	permitted	inside	the	labour	room.	Therefore	the	collection	process	may	be	conducted	in	a	sluice	or	dedicated	collection	room	within	the	hospital	(Machin,	Brown,	and	McLeod	2012).	The	donor	co-ordinators	or	phlebotomists	clean	the	cord,	hang	it	from	a	hook,	and	place	a	needle	in	the	cord,	so	the	blood	is	predominately	gravity-fed	into	a	UCB	sample	bag	(Jones	et	al.	2003;	Davey	et	al.	2004).		However,	what	happens	inside	the	labour	room	immediately	prior	to	this	can	vary	across	hospitals.	In	particular,	once	a	baby	is	born,	the	umbilical	cord	is	clamped	twice,	one	close	to	the	new	mother	and	the	other	close	to	the	baby.	In	2010,	a	survey	reported	that	74	percent	of	obstetricians	and	41	percent	of	midwives	in	the	UK	clamped	the	cord	within	20	seconds	after	a	baby	was	born	(Farrar	et	al.	2010).	Such	practice	was	conducted	as	part	of	a	range	of	activities	to	facilitate	control	over	the	uterus	and	the	delivery	of	the	placenta	in	the	final	stages	of	labour,	thereby	reducing	the	risk	of	the	woman	haemorrhaging	(Regan,	Bewley,	and	Warwick	2008;	Downey	and	Bewley	2012;	Duley	and	Batey	2013;	Royal	College	of	Obstetricians	and	Gynaecologists	2015).	Yet,	some	midwives	and	obstetricians	are	waiting	to	
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clamp	the	cord,	leaving	it	to	pulsate	between	two	to	five	minutes	after	the	baby	is	born.	Midwives	and	obstetricians	are	justifying	this	shift	in	practice	by	claiming	that	it	is	beneficial	for	the	baby	to	continue	to	receive	the	blood	within	the	cord	after	s/he	is	born	(Downey	and	Bewley	2012;	Hutchon	2012;	Mercer	and	Erickson-Owens	2014;	Royal	College	of	Obstetricians	and	Gynaecologists	2015).		The	decision	of	when	to	clamp	the	cord	does	not	happen	in	isolation	and	is	both	influential	of,	and	influenced	by,	how	the	third	stage	of	labour	is	managed.	In	particular,	a	woman	in	labour	may	opt	for	an	‘active’	third	stage	of	labour.	This	includes	the	umbilical	cord	being	clamped	within	30	seconds	to	a	minute	after	her	baby	is	born,	and	an	injection	of	drugs	with	the	aim	of	prompt	delivery	of	the	placenta	(Downey	and	Bewley	2012;	Duley	and	Batey	2013;	Brown	2013).	Alternatively,	a	woman	may	choose	a	‘physiological’	third	stage	of	labour,	which	can	mean	the	umbilical	cord	is	left	unclamped	until	it	finishes	pulsating,	and	the	woman’s	body	expels	the	placenta	without	pharmaceutical	encouragement	(Downey	and	Bewley	2012;	National	Institute	for	Health	and	Care	Excellence	2014).		For	the	stakeholders	in	UCB	collection	and	banking,	the	maternity	practices	of	clamping	the	cord	and	management	of	the	third	stage	of	labour	have	become	of	intense	interest	as	each	are	considered	as	having	implications	for	the	collection	of	‘quality’	UCB	samples.			
Methodology	The	data	used	in	this	article	is	the	result	of	a	two-year	project	funded	by	the	[removed	for	double	blind	review]	to	explore	the	policy	and	practice	implications	arising	from	the	introduction	of	the	UCB	banks.			
Participants	
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Potential	professional	and	lay	stakeholders	were	initially	identified	from	the	published	literature	on	UCB	and	were	deemed	“relevant”	due	to	their	existing	or	emerging	role	in	the	debates	surrounding	UCB	collection	and	banking	(Pinch	and	Bijker	1984)(for	a	visual	
interpretation	of	the	stakeholder	groups,	see	Machin,	Brown	and	McLeod	2012).	Additional	professional	and	lay	stakeholders	were	identified	via	interviewees’	suggestions.	Lay	stakeholders	-	women	and	men	who	had	or	were	considering	storing	UCB,	in	either	a	commercial	or	public	bank	in	England	-	were	recruited	through	advertising	on	local	and	national	websites,	in	parent	and	child	magazines,	and	with	the	assistance	of	UCB	banks.			
Ethical	Approval	Ethical	approval	was	granted	by	the	University	institution	[removed	for	double	blind	review]	and	the	NHS	National	Research	Ethics	Committee.	In	addition,	the	governance	requirements	for	nine	NHS	hospitals	in	England	were	met.			
Data	Collection	A	total	of	68	people	were	approached	to	take	part	in	the	project.	Two	declined	to	participate	in	the	project	due	to	time	commitments,	and	four	did	not	respond	to	the	recruitment	email.	Sixty	two	interviews	were	conducted	over	17	months	between	2009	and	2010	with	professional	and	lay	stakeholders	(see	Table	1).		A	focus	group	with	independent	midwives	(8)	was	also	conducted	during	this	time.	The	purpose	of	this	paper	is	to	explore	how	those	working	within	the	UCB	sector	and	on	maternity	wards	discuss	maternity	practices	in	light	of	the	recent	drive	for	collecting	‘quality’	UCB.	As	a	result,	the	interviews	from	these	stakeholder	groups	are	drawn	heavily	upon	throughout	the	paper.	The	experiences	of	pregnant	woman	and	parents	of	UCB	banking	are	considered	elsewhere	(see	Machin,	Brown	and	McLeod	2011;	Machin,	Brown	and	McLeod	2012).	
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Informed	consent	was	obtained	from	all	individual	participants	included	in	the	study.	The	interviews	were	semi-structured	in	order	to	provide	rich	and	in-depth	data.	This	also	allowed	participants	and	the	interviewer	the	freedom	and	flexibility	to	follow	up	topics	that	might	not	initially	have	been	considered	on	the	interview	guide	(Holstein	and	Gubrium	1995;	Kvale	1996).	The	interview	guide	covered	the	roles	and	relationships	within	UCB	banking,	as	well	as	discussion	of	maternity	practices	(see	Table	2).		Each	interview	lasted	between	60–120	minutes	and	were	recorded,	and	transcribed	in	full.		
	
Data	Analysis	Each	transcript	was	coded	for	themes	using	the	qualitative	data	package,	Atlas	ti.	Initially,	codes	reflected	very	broad	themes,	such	as	‘portrayal	of	UCB	banking’	and	‘portrayal	of	UCB,’	and	were	refined	with	each	reading	of	the	transcripts,	for	example	‘priorities	for	UCB.’	On	average,	each	transcript	was	read	three	times,	with	new	codes	emerging	with	each	reading,	such	as	‘portrayal	of	maternity	practices’	(see	Diagram	1).	Importantly,	any	“unexpected	issues”	(Seale	and	Kelly	1998)	that	emerged	during	the	reading	of	the	data,	for	example	‘compromises’	and	‘conflicts,’	were	also	acknowledged	and	resulted	in	further	refinement	of	the	codes.	Throughout	the	project,	analytical	summaries	and	interview	transcripts	were		compared	and	discussed	between	the	research	team	to	enhance	the	data	analysis.			
Findings	
Structure	of	the	Article	It	became	apparent	from	the	emerging	coding	that	participants	perceived	a	number	of	‘problems’	when	discussing	the	collection	of	‘quality’	UCB	and	maternity	practices	that	they	were	trying	to	reason	through.	For	some	participants,	the	problems	were	presented	as	conflicts,	or	involving	a	negotiation	between	competing	priorities,	or	requiring	a	compromise.	
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It	would	therefore	be	appropriate	to	frame	the	findings	of	this	article	within	a	decision-making	tool	that	aims	to	“facilitate	answers	to	the	question	‘what	should	I	do?’	in	the	specific	context	of	institutional	health	care	delivery”	(Steinkamp	and	Gordijn	2003).		This	is	a	novel	approach	to	the	field	of	UCB	collection	and	banking	as	it	is	designed	to	be	used	by	health	care	practitioners	to	consider	clinical	and	ethical	matters	jointly.	Clinical	pragmatism	is	a	flexible	method	of	problem	solving	through	a	process	of	inquiry,	discussion,	negotiation	and	reflective	evaluation	(Fins,	Bacchetta,	and	Miller	1997).	Clinical	pragmatism	is	not	a	point	of	view,	but	rather	a	way	of	understanding	and	responding	to	complicated	ethical	issues	in	health	care	(Fins	and	Bacchetta	1995).	Crucially,	the	method	focuses	upon	the	nuances	of	the	problem,	which	in	turn	“illuminates	the	thinking	of	practitioners,	the	expectations	of	patients…and	the	clinical	and	institutional	forces…”	at	play	(Fins	and	Bacchetta	1995).	It	is	democratic	in	its	approach,	with	no	stakeholders’	viewpoints	being	considered	more	significant	than	others	(Fins,	Bacchetta,	and	Miller	1997).		For	its	critics	(Jansen	1998),	the	purpose	of	clinical	pragmatism	may	only	be	to	augment	clinical	thinking	to	a	dilemma.	Yet,	it	still	provides	insight	into	the	interplay	between	stakeholders	(Steinkamp	and	Gordijn	2003)	and	therefore	how	this	plays	out	in	policy	and	practice	development.	Therefore,	this	article	follows	stages	of	the	clinical	pragmatism	approach,	from	the	‘problems’	emerging	for	stakeholders,	their	assessment	of	the	relevant	facts,	through	to	the	options	and	negotiation	throughout	the	problem-solving	enterprise,	concluding	with	an	evaluation	of	the	results.			
Diagnosing	the	(Moral)	Problem	From	a	clinical	pragmatist	perspective,	a	moral	problem	in	health	care	is	evident	when	people	are	conflicted	over	how	to	proceed	in	response	to	patient	care	(Fins,	Bacchetta,	and	Miller	1997;	Steinkamp	and	Gordijn	2003).	There	were	three	‘patients’	apparent	during	participants’	
	12		
interviews:	the	new	mother;	the	newborn	baby;	and	the	blood	disease	sufferer.	How	explicit	each	‘patient’	was	referred	to	varied	across	participants’	interviews	and	offered	insight	into	their	priorities	for	the	UCB.	Participants	presented	a	number	of	conflicts	around	the	care	of	these	three	patients,	which	were	at	various	stages	of	resolution.	In	particular,	when	participants	discussed	the	clamping	of	the	umbilical	cord,	the	conflict	existing	between	acquiring	a	‘quality’	UCB	sample	for	the	blood	disease	sufferers	and	concerns	for	maternal	and	neonatal	health	was	presented	as	unresolved.	For	example,	a	paediatric	haematologist	at	a	hospital	based	in	the	North	of	England	claimed	that	clamping	immediately	after	a	baby	was	born	meant	a	larger	volume	of	blood	remained	in	the	umbilical	cord.	As	a	result,	more	blood	was	available	to	collect	for	the	UCB	sample,	in	comparison	to	postponing	clamping	that	led	to	less	blood	in	the	cord	to	collect.	For	this	participant,	the	timing	of	when	the	umbilical	cord	was	clamped	influenced	the	‘quality’	of	UCB	samples,	but	also	acknowledged	“the	only	issue	that	we	might	have	a	concern	about	is	the	impact	(of	clamping)	on	the	mother	and	the	baby...”	(P87).	Therefore	the	timing	of	clamping	also	had	the	potential	to	influence	the	well-being	of	new	mothers	and	neonates.	For	this	haematologist,	there	was	a	restricted	amount	of	blood	within	the	umbilical	cord	and	therefore	an	optimal	time	to	clamp	the	cord	existed	according	to	which	‘patients’	were	considered	a	priority	–	the	new	mother	and	neonate,	or	the	blood	disease	sufferer.		Yet,	indirectly,	by	participants	discussing	the	implications	of	cord	clamping	on	UCB	collection,	an	additional,	related	problem	emerged,	whereby	maternal	health	was	pitched	as	in	competition	with	the	neonate’s	health,	as	the	following	quote	from	a	senior	policy	maker	illustrates;	There	is	the	question	about	clamping	itself...It’s	there	for	very	practical	reasons	to	stop	mothers	bleeding	to	death.	However,	there’s	still	a	debate	to	be	had	around	what	that	
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means	for	the	child	and	when	is	the	optimum	time	to	clamp	and	if	you	clamp	early	what	effect	that	has	on	the	child	in	later	life.	(P13)	The	policy	maker	presented	the	purpose	of	clamping	as	to	avoid	new	mothers	haemorrhaging,	but	created	the	possibility	that	the	practice	could	have	negative	implications	for	the	long-term	health	of	babies.	As	a	result,	it	can	be	inferred	that	the	participant	did	not	accept	that	the	stated	purpose	of	cord	clamping	to	protect	new	mothers	from	haemorrhaging	overruled	newborn	babies’	needs.	However,	the	participant	avoided	prioritising	either	‘patient’	when	claiming	that	an	‘appropriate’	time	to	clamp	the	umbilical	cord	remained	unknown.		The	uncertainty	around	the	timing	of	cord	clamping	was	at	the	heart	of	the	conflict	for	the	care	of	blood	disease	sufferers,	new	mothers	and	their	babies.	Such	uncertainty	was	reflected	in	the	varying	terminology	participants	used	when	discussing	the	timing	of	clamping	i.e.	early,	delayed,	immediate,	postponed,	as	well	as	how	these	clamping	practices	were	categorised.	Yet,	participants	still	presented	it	as	not	being	possible	to	clamp	the	umbilical	cord	at	a	time	that	was	mutually	beneficial	to	all	three	‘patients.’	In	essence,	to	acquire	the	volume	for	a	‘quality’	UCB	sample	to	treat	the	blood	disease	sufferer,	it	was	claimed	that	the	umbilical	cord	needed	to	be	clamped	at	a	time	that	was	also	beneficial	for	the	new	mother	to	avoid	her	haemorrhaging,	but	the	long-term	impact	on	the	newborn	baby’s	health	was	unknown.	Therefore,	the	problems	surrounding	cord	clamping	were	discussed	as	unresolved.	The	lack	of	resolution	appeared	to	stem	from	the	disputed	‘facts’	surrounding	the	practice,	in	particular	the	purpose	of	cord	clamping,	which	is	discussed	next.			
Assessing	the	Relevant	Facts	In	clinical	pragmatism,	the	‘facts’	can	relate	to	an	individual	patient’s	case,	as	well	as	taking	into	account	the	norms	that	exist	around	a	specific	problem	(Fins,	Bacchetta,	and	Miller	1997).	These	norms	may	derive	from	health	care	professionals’	opinions,	the	wishes	of	patients	and	
	14		
their	families,	as	well	as	“issues	of	power	or	conflict,	and	institutional	factors.”	(Steinkamp	and	Gordijn	2003)	When	discussing	the	problem	of	acquiring	the	volume	of	UCB	for	a	‘quality’	sample	and	protecting	maternal	and/or	neonatal	health,	participants	critically	evaluated	the	relevant	‘facts’	of	umbilical	cord	clamping	within	the	context	of	the	management	of	the	third	stage	of	labour.	In	particular,	participants	queried	the	norms	surrounding	cord	clamping	and	the	management	of	the	third	stage	of	labour,	which	in	turn	enabled	them	to	cast	doubt	over	the	purposes	of	the	practices.	For	example,	a	focus	group	with	independent	midwives	based	in	the	North	of	England	discussed	the	rationale	underlying	clamping	the	umbilical	cord	‘immediately’	as	part	of	‘active’	management	of	the	third	stage	of	labour,	which	can	also	include	women	receiving	an	injection	to	facilitate	the	delivery	of	the	afterbirth,							iv1:	30	years	ago	they	started	routinely	bringing	in	clamping	and	they	said,	babies	become	over-transfused.	Well,	they	weren’t	over-transfused	before	millennia	up	until	that	point...	iv2:	I	heard	them	[midwives]	say	to	women	do	you	want	an	injection	that	stops	you	from	bleeding	heavily	when	we	deliver	the	afterbirth.	I	mean,	who	is	going	to	say	no	to	that...	iv1:	And	now	a	reason	cited	that	women	give	for	why	they	want	to	have	the	injection	is	to	speed	it	up.	Now,	that’s	got	to	come	from	a	convenience	of	staff.	You	can’t	have	a	woman	hanging	around	on	a	labour	ward	for	five	hours.	(P16)		The	first	participant	implied	that	clamping	the	umbilical	cord	was	a	relatively	new	phenomenon	when	she	stated	that	the	practice	was	introduced	“30	years	ago,”	and	reinforced	this	portrayal	when	she	compared	it	to	practices	“before	millennia	up	until	that	point.”	The	division	in	time	that	the	independent	midwife	constructed	in	the	quote	enabled	her	to	create	the	image	of	clamping	within	active	management	as	lacking	‘evidence.’	As	a	result,	the	purpose	
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of	clamping	within	active	management	i.e.	to	avoid	“babies	becom[ing]	over-transfused”	is	brought	into	question.	Furthermore,	the	first	participant	claimed	that	clamping	within	active	management	practices	were	“routine,”	which	suggested	that	they	were	implemented	irrespective	of	new	mothers’	individual	needs.	Instead,	the	purpose	of	active	management	practices,	such	as	clamping	and	an	injection	to	facilitate	delivery	of	the	afterbirth,	were	implied	to	benefit	hospital	staff.	Consequently,	institutional	factors,	such	as	lack	of	staff	and	bed	shortages,	were	conjured	when	the	independent	midwives	described	components	of	active	management	as	convenient	for	hospital	staff	and	to	avoid	“women	hanging	around	on	a	labour	ward.”	The	depiction	of	the	purpose	of	active	management	practices	as	convenient	for	hospital	staff	also	undermined	the	implied	health	professionals’	beliefs	of	active	management	practices	claimed	by	the	second	independent	midwife	-		“an	injection	that	stops	you	from	bleeding	heavily...”	In	turn,	the	labouring	women’s	wishes	to	have	an	injection	“to	speed	it	up”	were	delegitimized.	The	independent	midwives	implied	that	if	women	were	aware	of	the	‘true’	purpose	of	active	management	practices	i.e.	convenience	for	hospital	staff,	they	would	be	less	likely	to	agree	to	them	taking	place.	Moreover,	if	the	practices	of	active	management	are	not	carried	out	to	protect	maternal	health,	then	doubt	is	cast	over	whether	they	should	be	conducted	at	all,	and	we	are	led	to	question	what	implications	they	might	have	for	maternal	and	neonatal	health.	Such	doubt	and	questioning	have	the	potential	to	be	significant	for	the	collection	of	a	‘quality’	UCB	sample	as	there	would	be	less	blood	available	in	the	umbilical	cord	to	collect	if	active	management	was	not	carried	out,	and	the	presentation	of	physiological	management	of	the	third	stage	of	labour	could	be	viewed	as	beneficial	to	maternal	and	neonatal	health.		When	participants	were	asked	about	the	potential	benefits	of	physiological	management	practices,	which	can	entail	‘deferring’	clamping	the	umbilical	cord,	they	frequently	referred	to	the	‘evidence’	surrounding	it.	Whilst	participants	acknowledged	the	
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existence	of	‘evidence’	relating	to	the	physiological	management	practices,	they	were	keen	to	highlight	its	limitations,	which	generated	uncertainty	over	the	purpose	of	the	practices.	One	such	limitation	was	how	‘applicable’	the	evidence	was	to	the	context	being	addressed.		For	example,	a	director	of	a	commercial	UCB	bank	discussed	deferring	cord	clamping	when	aiming	for	a	‘quality’	UCB	sample,						There	is	a	view	that	when	baby	is	born	some	people	will	eat	the	placenta.	Some	people	will	take	the	placenta	and	bury	it	in	the	garden.	Some	people	will	insist	that	the	placenta	is	attached	to	the	baby	until	it	is	delivered.	Strange	things	like	that.	Current	medical	practice	in	most	of	the	developed	world	is	that	a	baby	is	born,	the	cord	is	clamped.	(P3)	The	reference	to	the	“developed	world”	in	the	extract	implied	that	the	other	practices,	such	as	eating	or	burying	the	placenta,	were	carried	out	in	the	developing	world,	of	which	deferred	cord	clamping	–	“Some	people	will	insist	that	the	placenta	is	attached	to	the	baby	until	it	is	delivered”	–	was	associated	with.	The	participant	shrouded	the	practice	of	deferred	cord	clamping	in	mystic	by	comparing	it	to	other	“strange”	actions	with	the	placenta	once	a	baby	is	born.	In	effect,	deferred	cord	clamping	was	something	to	be	viewed	as	exotic	and	unusual	within	the	developed	world,	which	created	an	uncertainty	around	the	purpose	of	the	practice.	When	the	director	framed	immediate	cord	clamping	–	“a	baby	is	born,	the	cord	is	clamped”	–	as	within	“current	medical	practice,”	it	positioned	deferred	cord	clamping	as	outside	of	it	and	instead	associated	it	with	‘non-medical’	or	‘outdated’	medical	practices.	The	distinction	of	‘non-medical’	or	‘outdated’	medical	practices	proved	useful	for	the	director	of	the	UCB	bank	as	it	positioned	deferred	cord	clamping	as	lacking	a	‘medical’	basis	for	its	application	in	the	developed	world.	Conversely,	immediate	cord	clamping	was	not	implied	to	be	detrimental	to	the	heath	of	babies	born	in	developed	countries,	like	UK,	and	in	turn	made	collecting	UCB	for	blood	disease	sufferers	after	immediate	cord	clamping	had	taken	place,	as	acceptable.	It	appeared	therefore	that	when	faced	with	the	conflict	of	caring	for	all	three	patients	when	
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clamping	the	umbilical	cord,	some	participants,	such	as	independent	midwives	and	the	UCB	bank	director,	adopted	polarised	positions	i.e.	immediate	or	deferred	clamping	was	deemed	to	be	harmful	for	either	maternal	or	neonatal	health.	Yet,	when	asked	how	to	overcome	the	opposing	viewpoints	to	the	conflict,	participants,	including	the	independent	midwives	and	the	UCB	bank	director,	proposed	a	number	of	options	that	acted	as	compromises.	A	closer	look	at	these	compromises	provided	insight	into	participants’	goals	for	patient	care	i.e.	which	patient’s	health	was	considered	priority	in	the	conflict,	as	well	as	suggest	that	a	series	of	negotiations	had	taken	place.			
Goals,	Options,	and	Negotiating	a	Decision	The	clinical	pragmatism	approach	proposes	that	the	goals	of	care	are	agreed	between	stakeholders	and	plausible	ways	to	proceed	in	the	conflict	are	considered	(Fins,	Bacchetta,	and	Miller	1997).	Discussions	around	the	collection	of	‘quality’	UCB	samples	implied	the	health	of	blood	disease	sufferers	as	a	goal	of	care,	and	initiated	the	protection	of	maternal	and	neonatal	health	as	an	additional	goal	of	care	for	participants.	Whilst	these	goals	of	care	were	agreed	between	participants,	they	were	also	prioritised,	as	a	quote	from	a	mother	who	had	stored	UCB	in	a	commercial	bank	illustrates,	“...at	the	end	of	the	day,	you’re	in	labour	and	it’s	the	safety	of	the	mother	and	baby	that	is	the	first	priority...”	(P69).	For	this	participant,	the	hierarchy	of	goals	were	the	safety	of	mother	and	baby,	then	collecting	UCB.	UCB	for	blood	disease	sufferers	as	a	secondary	concern	to	protecting	maternal	and	neonatal	health	was	also	explicitly	agreed	upon	between	participants,	for	example	an	obstetrician	stated,	“The	most	important	thing,	like	most	things	in	life,	is	actually	the	baby	being	born.	The	UCB	banking	actually	is	a	secondary	issue”	(P65)	and	a	director	of	a	commercial	UCB	bank	claimed,	“...the	priority	is	to	mum	and	baby”	(P4).	Echoes	of	this	prioritisation	was	also	apparent	in	the	discourse	of	those	whose	work	was	associated	with	UCB	treatment,	as	the	following	extracts	from	a	senior	policy	maker	
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and	public	banker	respectively	demonstrates,	“Plainly	the	priority	of	UCB	is	to	service	the	baby...any	guidance	on	collection	has	to	give	absolute	priority	and	primacy	to	the	baby	and	the	mother”	(P7)	and	“...even	taking	time	to	do	the	clamping	I	think	it’s	enough	blood	to	have	a	clinical	unit	for	transplant	to	a	patient”	(P1).		In	order	to	achieve	these	agreed	goals,	a	number	of	options	were	discussed,	which	revolved	around	the	timing	of	clamping	the	umbilical	cord	and	the	volume	of	UCB	collected.	For	example,	the	director	of	a	commercial	UCB	bank,	a	public	bank	member,	and	two	obstetricians	at	hospitals	in	Southern	England	proposed	a	cap	to	the	volume	of	UCB	collected	for	a	‘quality’	sample	to	treat	blood	disease	sufferers.	In	the	data,	reference	to	40mls	as	the	required	value	for	a	‘quality’	UCB	sample	to	treat	blood	disease	sufferers	was	accepted	by	all	participants,	and	as	a	consequence,	created	a	flexibility	regarding	the	timing	of	when	the	umbilical	cord	could	be	clamped,	as	a	quote	from	an	obstetrician	illustrates,	“...in	fact	you	might	be	able	to	get	to	some	kind	of	compromise	that	we	clamp	for	a	minute	and	then	you	get	40mls”	(P63).	The	flexibility	appeared	to	stem	from	a	desire	to	help	blood	disease	sufferers	via	UCB	collection,	as	well	as	the	neonate	by	prolonging	the	passing	of	blood	through	the	umbilical	cord	before	clamping	it.	Yet,	clamping	would	take	place	to	avoid	risking	the	health	of	the	mother.	In	the	quote,	the	obstetrician	implied	that	the	UCB	itself	might	contain	beneficial	properties	for	the	neonate.	This	potential	in	UCB	was	recognised	by	a	woman	who	had	paid	to	store	UCB	in	a	private	bank,	and	a	member	of	a	public	UCB	bank	who	both	described	how	the	third	stage	of	labour	was	adapted	so	that	the	‘beneficial’	elements	from	‘deferring’	clamping	the	umbilical	cord	were	generated,	as	well	as	the	advantages	of	immediate	clamping	for	UCB	collection	being	established,	“…we	are	taking	time	to	clamp	the	cord...i	think	it’s	enough	blood	to	have	a	clinical	unit	for	transplant	to	a	patient”	(P1)	and,	“...she	[midwife]	didn’t	allow	them	to	clamp	it	too	early.	She	let	basically	a	flow	go	through	for	a	few	minutes	so	that	the	baby	got	the	essentials	and	then	clamped	it	after	that”	(P53).	
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The	idea	that	the	blood	inside	the	umbilical	cord	could	be	beneficial	to	the	neonate’s	health	after	being	born	had	the	potential	to	portray	UCB	collection	and	immediate	cord	clamping	in	a	negative	light,	especially	when	the	agreed	goal	of	care	between	participants	was	maternal	and	neonatal	health	as	priorities.	Therefore	the	option	to	limit	the	volume	of	UCB	as	proposed	by	as	a	commercial	UCB	bank	director	created	the	image	of	a	‘small’	proportion	of	the	available	blood	being	collected,	which	would	not	jeopardise	the	neonate’s	health,	“...You	drain	as	much	[UCB]	as	you	like	into	that	baby.	There’s	plenty.	That	placenta	puts	out	an	enormous	amount.	We	only	need	40ml”	(P4).		However,	whilst	the	option	to	restrict	the	volume	of	UCB	collected	was	universally	agreed	upon	by	participants,	the	option	to	combine	elements	of	immediate	and	deferred	cord	clamping	was	presented	as	potentially	risky	to	maternal	health	as	two	quotes	from	midwives	illustrate,		We	ended	up	going	for	a	compromise	of	feeling	the	cord	pulses	when	the	baby	had	started	breathing	and	then	clamping,	which	is	obviously	slightly	mixing	management	which	sometimes	can	increase	the	chance	of	bleeding	[for	the	woman]	(P16)	And,	“…we’re	looking	at	doing	a	halfway	house	on	the	management	of	the	third	stage	of	labour…delay	clamping	if	the	baby	is	okay	and	the	mother	is	okay…”	(P76)	Although	mixing	management	was	often	proposed	by	participants,	the	riskiness	of	this	option	made	it	difficult	for	participants	to	fully	support	it	when	faced	with	the	conflict	to	collect	‘quality’	UCB.	In	contrast,	the	option	to	limit	the	volume	of	UCB	collected	was	presented	by	participants	as	having	little	or	no	interference	to	maternity	practices	i.e.	midwives	and	obstetricians	could	decide	whether	to	conduct	immediate	or	deferred	cord	clamping,	and	was	therefore	presented	as	the	better	option.		This	difference	in	acceptance	over	the	two	options	is	significant	as	both	were	presented	by	participants	as	compromises	–	“we	only	need	40ml”	and	“halfway	house”	–	but	only	one	was	
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accepted.	In	essence,	these	proposed	compromises	were	forms	of	negotiation	over	the	UCB	itself	and	who	should	benefit	from	it	i.e.	the	neonate	or	blood	disease	sufferer,	between	those	involved	in	UCB	collection	practices	and	those	carrying	out	maternity	practices.	The	results	of	these	negotiated	compromises	are	evaluated	next.			
Conclusion:	Evaluating	the	Results	This	study	has	advanced	understanding	of	the	current	debates	surrounding	the	collection	of	UCB	through	adopting	a	clinical	pragmatist	approach	and	interpreting	the	findings	within	compromise	literature.	This	is	achieved	by	considering	the	relationships	between	those	in	the	UCB	banking	sector	and	those	conducting	maternity	practices.	The	clinical	pragmatist	approach	highlighted	that	key	stakeholders	involved	in	the	collection	of	UCB	are	positive	regarding	the	protection	of	maternal	and	neonatal	health,	whilst	those	conducting	maternity	practices	are	not	opposed	to	facilitating	the	collection	of	‘quality’	UCB.	Therefore	previous	portrayals	of	midwives	and	obstetricians	as	opposed	or	objecting	to	UCB	collection	were	challenged,	and	emerging	areas	of	potential	agreement	between	previously	opposed	stakeholders	(Fins,	Bacchetta,	and	Miller	1997)	have	been	identified.	For	the	UK	government	and	policy	makers,	awareness	of	such	areas	could	prove	useful	when	attempting	to	shifts	debate	forward	in	the	drive	for	‘quality’	UCB.			Midwives,	obstetricians,	and	UCB	bankers	attempted	to	find	a	way	for	UCB	to	be	collected	without	jeopardising	maternal	and	neonatal	health.	This	compromising	aspect	of	the	options,	in	particular	the	consideration	of	other	stakeholders’	needs	or	requirements,	suggested	midwives,	obstetricians,	and	UCB	bankers	acknowledged	the	‘significance’	of	their	place	in	the	debates	surrounding	the	collection	of	‘quality’	UCB	(Nachi	2004;	Menkel-Meadow	2006).	In	effect,	if	midwives,	obstetricians,	and	UCB	bankers	did	not	deem	each	other	to	be	
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influential	in	the	debates,	then	there	would	be	little	motivation	to	compromise	their	own	requirements	in	an	attempt	to	meet	others’	demands.	By	adopting	a	clinical	pragmatist	approach,	this	study	has	also	brought	hidden	nuances	arising	from	the	debate	surrounding	the	collection	of	‘quality’	UCB	to	the	fore,	which	highlight	how	policy	and	practice	are	influenced	today.	For	example,	participants	challenged	the	evidence	available	on	the	importance	of	deferred	cord	clamping	for	neonates	born	in	Western	Societies.	It	was	surprising	therefore	for	participants	to	agree	upon	the	option	that	facilitated	some	UCB	being	passed	to	the	neonate.	This	option	required	the	activities	of	those	involved	in	UCB	collection	to	be	restricted	and	limited	in	some	way.	Equally,	the	alternative	option	of	mixing	management	of	the	third	stage	of	labour	required	a	shift	in	maternity	practices,	and	was	therefore	opposed	mostly	by	those	conducting	maternity	practices.	This	is	telling	because	it	suggests	that	those	powerful	in	the	debates	are	those	conducting	maternity	practices	(Steinkamp	and	Gordijn	2003;	Arnsperger	and	Picavet	2004;	Menkel-Meadow	2006).	In	contrast,	UCB	bankers	have	less	influence	within	the	debates,	perhaps	arising	from	the	lower	priority	of	UCB	collection	in	the	goals	of	patient	care	highlighted	via	the	clinical	pragmatist	approach.	The	power	imbalance	between	stakeholders	found	in	this	study	supports	previous	commentary	on	UCB	banking	(Fisk	and	Atun	2008)	which	positioned	midwives	and	obstetricians	in	influential	positions	in	determining	the	future	of	UCB	collection.	As	the	drive	for	‘quality’	UCB	intensifies,	so	too	does	the	need	for	the	UK	government	and	policy	makers	to	engage	with	these	powerful	stakeholders.		But	the	balancing	of	power	can	shift	between	stakeholders,	if	understanding	around	particular	practices	shift	in	light	of	emerging	evidence	(Papilloud	and	Rol	2004;	Hussenot	2010).		Adopting	a	clinical	pragmatist	approach	has	flagged	two	aspects	of	the	debates	surrounding	the	acquisition	of	‘quality’	UCB	that	have	the	potential	to	challenge	current	understanding	and	therefore	shape	power	dynamics	between	stakeholders.	Firstly,	the	
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purpose	of	cord	clamping	was	destabilised	when	participants	challenged	the	‘evidence’	for	its	application.	Participants	in	this	study	questioned	if	the	purpose	of	cord	clamping	was	to	protect	the	new	mother’s	health	–	“stop	women	bleeding	heavily;”	facilitate	the	health	of	the	neonate	–	“prevent	babies	from	becoming	over-transfused;”	or	relieve	the	blood	disease	sufferers	–	“enough	blood	for	a	clinical	unit.”	Future	findings	from	research	being	conducted	by	midwives	and	obstetricians	regarding	the	implications	of	cord	clamping	on	neonates	(Mercer	and	Erickson-Owens	2014)	will	undoubtedly	contribute	to,	and	continue,	the	destabilisation	of	understanding	surrounding	the	purpose	and	practice	of	cord	clamping,	which	in	turn	has	the	potential	to	influence	and	undermine	the	present	balance	of	power	between	stakeholders	(Papilloud	and	Rol	2004;	Hussenot	2010).		Secondly,	underpinning	participants’	discussions	of	a	‘quality’	UCB	sample	was	the	assumption	that	clamping	‘immediate’	enabled	a	larger	volume	of	blood	to	remain	in	the	umbilical	cord,	which	left	more	blood	to	be	collected.	Conversely,	if	cord	clamping	was	deferred,	it	was	assumed	that	there	would	be	less	blood	in	the	umbilical	cord	for	collection	(Andersson	et	al.	2011;	Burgess	and	Hilton	2012).	Therefore,	in	practice,	the	collection	of	a	‘quality’	UCB	sample	was	dictated	by	the	timing	of	cord	clamping,	and	the	volume	of	blood	collected	determined	a	‘quality’	UCB	sample.	However,	participants	in	this	study	undermined	this	assumption	when	they	discussed	the	option	to	restrict	the	volume	of	UCB	collected,	which	they	described	as	still	permitting	a	‘quality’	UCB	sample	to	be	achieved,	without	imposing	upon	the	timing	of	when	the	cord	is	clamped.		The	findings	from	this	study	suggest	further	research	is	needed	to	explore	the	meanings	surrounding	‘quality’	UCB	samples	in	stem	cell	treatments	and	to	include	the	voices	of	those	involved	in	using	UCB	in	treatments,	which	were	not	included	in	this	study.	Such	research	has	the	potential	to	also	undermine	the	existing	balance	of	power	between	stakeholders	if	understanding	regarding	practices	that	determine	a	‘quality’	UCB	sample	shift.			
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